Tag: arcellxbiohealth

Articles and events tagged with this topic across BioBuzz’s regional hubs.

Articles

Research Triangle Park Industry Trends Press Release

Arcellx Announces FDA Clearance of IND Application for ACLX-001, a Controllable Cell Therapy Utilizing the Company’s ARC-SparX Platform, for the Treatment of Multiple Myeloma

December 2, 2024

Research Triangle Park

Research Triangle Park Funding Press Release

Arcellx Closes $115 Million Series C Financing to Advance its Pipeline of Adaptive and Controllable Cell Therapies

December 2, 2024

Research Triangle Park

Research Triangle Park People Editorial

Arcellx Announces Kate Aiken as Chief People Officer

December 2, 2024

Research Triangle Park

BioHealth Capital Region Industry Trends Press Release

Arcellx Announces Pricing of Initial Public Offering

December 2, 2024

BioHealth Capital Region

Research Triangle Park Industry Trends Press Release

Arcellx Announces Closing Of Upsized Public Offering Of Common Stock And Underwriters’ Full Exercise Of Option To Purchase Additional Shares

December 2, 2024

Research Triangle Park

Greater Philadelphia Industry Trends Press Release

Kite to Bolster Cell Therapy Capabilities through Acquisition of Carl June’s Tmunity Therapeutics

December 2, 2024

Greater Philadelphia

Events

No upcoming events tagged “arcellxbiohealth”.